Litcius/Paper detail

Safety and efficacy of amantadine, modafinil, and methylphenidate for fatigue in multiple sclerosis: a randomised, placebo-controlled, crossover, double-blind trial

Bardia Nourbakhsh, Nisha Revirajan, Bridget Morris, Christian Cordano, Jennifer M. Creasman, Michael Manguinao, Kristen M. Krysko, Alice Rutatangwa, Caroline Auvray, Salman Aljarallah, Chengshi Jin, Ellen M. Mowry, Charles E. McCulloch, Emmanuelle Waubant

2020The Lancet Neurology170 citationsDOIOpen Access PDF

Topics & Concepts

ModafinilAmantadineMethylphenidateCrossover studyPlaceboMedicineDouble blindMultiple sclerosisAnesthesiaPsychologyPharmacologyPsychiatryAttention deficit hyperactivity disorderAlternative medicinePathologyMultiple Sclerosis Research StudiesLong-Term Effects of COVID-19Peripheral Neuropathies and Disorders
Safety and efficacy of amantadine, modafinil, and methylphenidate for fatigue in multiple sclerosis: a randomised, placebo-controlled, crossover, double-blind trial | Litcius